| Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
| HY-103447 |
Zearalenone |
Activator |
98.95% |
Unkown |
| HY-18777 |
KC7F2 |
Inhibitor |
99.36% |
Unkown |
| HY-112904 |
XRK3F2 |
Inhibitor |
99.08% |
Unkown |
| HY-156190A |
NR2F2-IN-1 free base |
Inhibitor |
99.31% |
Unkown |
| HY-15480 |
NSC 42834 |
Inhibitor |
96.85% |
Unkown |
| HY-125848 |
Ginsenoside F2 |
|
99.92% |
Unkown |
| HY-153916 |
TCRS-417 |
|
99.13% |
Unkown |
| HY-Y0110 |
2-Naphthol |
|
99.91% |
Unkown |
| HY-113209 |
8-Isoprostaglandin F2α |
|
99.9% |
Unkown |
| HY-150270A |
NP-1815-PX sodium |
|
99.51% |
Unkown |
| HY-156876 |
20-HETE inhibitor-2 |
Inhibitor |
99.17% |
Unkown |
| HY-149894 |
MC-1-F2 |
Inhibitor |
99.69% |
Unkown |
| HY-12956S |
Dinoprost-d4 |
|
99.9% |
Unkown |
| HY-107381 |
(+)-Cloprostenol |
Agonist |
98.06% |
Unkown |
| HY-147058 |
SW2_152F |
Inhibitor |
99.51% |
Unkown |
| HY-103462 |
TC-F2 |
Inhibitor |
99.35% |
Unkown |
| HY-180561 |
WWQ-03-012 |
|
98.04% |
Unkown |
| HY-E70133 |
Endo-β-N-acetylglucosaminidase F2 |
|
/ |
Unkown |
| HY-103447R |
Zearalenone (Standard) |
Activator |
98.85% |
Unkown |
| HY-103447S1 |
Zearalenone-13C18 |
|
98.7% |
Unkown |
| HY-154992 |
2,4-Difluorophenylethynylcobalamin |
|
98.97% |
Unkown |
| HY-W075400 |
4,9-Dibromonaphtho[2,3-c][1,2,5]thiadiazole |
|
96.60% |
Unkown |
| HY-113209S |
8-Isoprostaglandin F2α-d4 |
|
98.41% |
Unkown |
| HY-113246 |
15-keto-Prostaglandin F2a |
|
99.2% |
Unkown |
| HY-118816 |
11β-Prostaglandin F2α |
|
95.0% |
Unkown |
| HY-121314 |
Cloprostenol |
|
99.86% |
Unkown |
| HY-151810 |
TP0472993 |
Inhibitor |
98.22% |
Unkown |
| HY-162142 |
BB2-50F |
|
98.60% |
Unkown |
| HY-100571 |
Cloprostenol isopropyl ester |
Agonist |
98.0% |
Unkown |
| HY-118388 |
AS604872 |
Antagonist |
/ |
Unkown |
| HY-130660 |
Prostaglandin F2α ethanolamide |
Agonist |
98.2% |
Unkown |
| HY-151809 |
CYP4A11/CYP4F2-IN-1 |
Inhibitor |
99.82% |
Unkown |
| HY-113208 |
13,14-Dihydro-15-keto Prostaglandin F2α |
|
99.0% |
Unkown |
| HY-129953 |
9α,11β-Prostaglandin F2α |
|
99.9% |
Unkown |
| HY-RS04631 |
F2R Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-Y0110S1 |
2-Naphthol-d7 |
|
99.37% |
Unkown |
| HY-144881 |
(S)-HH2853 |
Inhibitor |
/ |
Unkown |
| HY-111478 |
Tiaprost |
|
98.0% |
Unkown |
| HY-114810 |
Prostaglandin F2α serinol amide |
Agonist |
99.41% |
Unkown |
| HY-131632 |
1a,1b-Dihomo prostaglandin F2α |
|
/ |
Unkown |
| HY-132277S |
15-Keto Bimatoprost-d5 |
|
96.65% |
Unkown |
| HY-137119 |
(±)5-iPF2α-VI |
Control |
99.0% |
Unkown |
| HY-144882 |
(R)-HH2853 |
Inhibitor |
/ |
Unkown |
| HY-156190 |
NR2F2-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-B0577S |
Latanoprost-d4 |
Agonist |
98.0% |
Unkown |
| HY-RS04634 |
F2RL1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS04637 |
F2RL2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS09542 |
NR2F2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-125946 |
Latanoprost lactone diol |
|
99.86% |
Unkown |
| HY-W726201 |
5'-DMT-5-F-2'-dU Phosphoramidite |
|
98.0% |
Unkown |
| HY-103447R1 |
Zearalenone in Acetonitrile (Standard) |
Activator |
/ |
Unkown |
| HY-112904A |
XRK3F2 free base |
Inhibitor |
/ |
Unkown |
| HY-113208A |
11β-13,14-Dihydro-15-keto Prostaglandin F2α |
|
/ |
Unkown |
| HY-113208AS1 |
11β-13,14-Dihydro-15-keto Prostaglandin F2α-d4 |
|
/ |
Unkown |
| HY-113209A |
ent-8-Iso-15(S)-prostaglandin F2α |
|
/ |
Unkown |
| HY-113209R |
8-Isoprostaglandin F2α (Standard) |
|
/ |
Unkown |
| HY-113209S2 |
8-Isoprostaglandin F2α-13C5 |
|
/ |
Unkown |
| HY-113459S1 |
13,14-Dihydro-15-keto Prostaglandin F2α-d4 |
|
/ |
Unkown |
| HY-113756B |
rel-Latanoprost acid |
Agonist |
/ |
Unkown |
| HY-113778 |
15-keto-17-phenyl trinor Prostaglandin F2α |
|
/ |
Unkown |
| HY-113909 |
Dinoprost (methoxyamine) |
|
/ |
Unkown |
| HY-114387 |
Dipyrazino[2,3-f:2',3'-h]quinoxaline |
|
/ |
Unkown |
| HY-114593 |
ent-8-iso Prostaglandin F2α |
|
/ |
Unkown |
| HY-114687 |
5,7-Dihydroxy-11-ketotetranorprostanoic acid |
|
/ |
Unkown |
| HY-114695S |
Prostaglandin F2α-1-glyceryl ester-d5 |
|
/ |
Unkown |
| HY-114761 |
Prostaglandin F2α dimethyl amine |
Antagonist |
/ |
Unkown |
| HY-114850 |
5-trans Prostaglandin F2β |
|
/ |
Unkown |
| HY-114850A |
(5R)-Dinoprost tromethamine |
|
/ |
Unkown |
| HY-116051 |
16,16-Dimethylprostaglandin F2α |
|
/ |
Unkown |
| HY-116051A |
16,16-Dimethylprostaglandin F2β |
|
/ |
Unkown |
| HY-116161 |
Bimatoprost isopropyl ester |
|
/ |
Unkown |
| HY-116549 |
Prostaglandin F2α alcohol |
Agonist |
/ |
Unkown |
| HY-116591 |
8-Iso-15-keto prostaglandin F2β |
|
/ |
Unkown |
| HY-116704 |
11-Deoxyprostaglandin F2α |
Modulator |
/ |
Unkown |
| HY-117061 |
Prostaglandin F2α alcohol methyl ether |
Agonist |
/ |
Unkown |
| HY-118190 |
AL 8810 methyl ester |
Agonist |
/ |
Unkown |
| HY-118294 |
15-OH Tafluprost |
Control |
/ |
Unkown |
| HY-118599 |
Prostaglandin F2α ethyl amide |
|
/ |
Unkown |
| HY-118648 |
Prostaglandin F2α methyl ester |
Agonist |
/ |
Unkown |
| HY-120197 |
17-Phenyl trinor prostaglandin F2α methyl amide |
Inhibitor |
/ |
Unkown |
| HY-120955 |
(+)-5-trans Cloprostenol |
Control |
/ |
Unkown |
| HY-124200 |
AL 8810 isopropyl ester |
|
/ |
Unkown |
| HY-125150 |
AL-3138 |
Antagonist |
/ |
Unkown |
| HY-125396 |
11-Deoxyprostaglandin F2β |
|
/ |
Unkown |
| HY-125626 |
8-iso-15-keto Prostaglandin F2α |
Agonist |
/ |
Unkown |
| HY-129397S |
2,3-Dinor-11β-prostaglandin F2α-d9 |
|
/ |
Unkown |
| HY-12956B |
(5R)-Dinoprost |
|
/ |
Unkown |
| HY-12956S1 |
Dinoprost-d9 |
|
/ |
Unkown |
| HY-12956S2 |
Dinoprost-13C5 |
|
/ |
Unkown |
| HY-129953A |
5-trans Prostaglandin F2α |
|
/ |
Unkown |
| HY-129953B |
15(R)-Prostaglandin F2α |
|
/ |
Unkown |
| HY-129953C |
5-trans Prostaglandin F2α tromethamine |
|
/ |
Unkown |
| HY-129953F |
Prostaglandin F2α-biotin |
|
/ |
Unkown |
| HY-129953S |
9α,11β-Prostaglandin F2α-d4 |
|
/ |
Unkown |
| HY-129953S1 |
9α,11β-Prostaglandin F2α-d9 |
|
/ |
Unkown |
| HY-131617 |
Prostaglandin F2α 1,11-lactone |
Control |
/ |
Unkown |
| HY-132277 |
15-Keto Bimatoprost |
Control |
/ |
Unkown |
| HY-136494 |
Fluprostenol |
|
/ |
Unkown |
| HY-137024 |
15-Keto-PGA1 |
Activator |
/ |
Unkown |
| HY-137412 |
PGF2α 1,15-lactone |
|
/ |
Unkown |
| HY-137504 |
20-ethyl Prostaglandin F2α |
|
/ |
Unkown |
| HY-137544 |
16-Phenyl tetranor Prostaglandin F2α |
|
/ |
Unkown |
| HY-137585 |
17-Trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F2α |
Control |
/ |
Unkown |
| HY-138244 |
8-iso Prostaglandin F2β |
|
/ |
Unkown |
| HY-139063 |
16-Phenoxy tetranor prostaglandin F2α |
|
/ |
Unkown |
| HY-139119 |
Prostaglandin F2α dimethyl amide |
Antagonist |
/ |
Unkown |
| HY-139121 |
15(R)-17-Phenyl trinor Prostaglandin F2α |
Agonist |
/ |
Unkown |
| HY-139124 |
15(R)-15-Methyl Prostaglandin F2α |
Agonist |
/ |
Unkown |
| HY-139499 |
Sudemycin D6 |
Modulator |
/ |
Unkown |
| HY-141637S |
2-Deoxy-2-fluoro-D-glucose-13C |
|
99.48% |
Unkown |
| HY-141637S1 |
2-Deoxy-2-fluoro-D-glucose-13C6,d7 |
|
/ |
Unkown |
| HY-149554 |
17-Phenyl trinor Prostaglandin F2α dimethyl amide |
|
/ |
Unkown |
| HY-149770 |
CYP4A11/CYP4F2-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-149926 |
Cathepsin Inhibitor 3 |
|
/ |
Unkown |
| HY-150270 |
NP-1815-PX |
|
/ |
Unkown |
| HY-151190 |
cis-4-Br-2,5-F2-PCPA |
Inhibitor |
/ |
Unkown |
| HY-151453 |
Topoisomerase IIα-IN-4 |
|
/ |
Unkown |
| HY-154606 |
2'-F-2'-ara-N2-ibu-dG Phosphoramidite |
|
/ |
Unkown |
| HY-154854 |
BBDDL2059 |
Inhibitor |
/ |
Unkown |
| HY-157292 |
2E-3-F16 |
|
/ |
Unkown |
| HY-158450 |
FA2G2 glycan (G2F), 2-AB labelled |
|
/ |
Unkown |
| HY-158459 |
A2G2F2 glycan |
|
/ |
Unkown |
| HY-158478 |
FA2[3]G1 & FA2[6]G1 glycan (G1F), 2-AB labelled |
|
/ |
Unkown |
| HY-158481 |
FA2[3]G1 & FA2[6]G1 glycan (G1F), 2-AA labelled |
|
/ |
Unkown |
| HY-158499 |
FA2 glycan (G0F), 2-AA labelled |
|
/ |
Unkown |
| HY-158500 |
FA2 glycan (G0F), 2-AB labelled |
|
/ |
Unkown |
| HY-158571 |
17-Phenoxy trinor prostaglandin F2α |
|
/ |
Unkown |
| HY-158595 |
15(R),19(R)-Hydroxy prostaglandin F2α |
|
/ |
Unkown |
| HY-158937 |
15(R)-15-Methyl prostaglandin F2α methyl ester |
Control |
/ |
Unkown |
| HY-163376 |
17-Trifluoromethylphenyl trinor prostaglandin F2α ethyl amide |
|
/ |
Unkown |
| HY-163552 |
Prostaglandin F2a/BSA |
|
/ |
Unkown |
| HY-168890 |
TRF2-IN-1 |
|
/ |
Unkown |
| HY-172574 |
8-iso-17-Phenyl trinor prostaglandin F2α |
|
/ |
Unkown |
| HY-175105 |
17-Phenoxy trinor prostaglandin F2α isopropyl ester |
|
/ |
Unkown |
| HY-176011 |
17-Phenyl trinor prostaglandin F2α glycinamide methyl ester |
Agonist |
/ |
Unkown |
| HY-181443 |
15(S)-15-Methyl Prostaglandin F2α ethyl amide |
|
/ |
Unkown |
| HY-183844 |
C5F2-HCB |
|
/ |
Unkown |
| HY-184078 |
8-F-2-(Me-Pip-Me)-Tryptanthrin |
Inhibitor |
/ |
Unkown |
| HY-184165 |
F2F-202 |
Inhibitor |
/ |
Unkown |
| HY-D0160 |
ZnAF-2F |
|
/ |
Unkown |
| HY-D0161 |
ZnAF-2F DA |
|
/ |
Unkown |
| HY-E71195 |
15-Hydroxyprostaglandin dehydrogenase (NAD+) |
|
/ |
Unkown |
| HY-E71196 |
15-Hydroxyprostaglandin dehydrogenase (NADP+) |
|
/ |
Unkown |
| HY-N12119 |
ent-Prostaglandin F2α |
|
/ |
Unkown |
| HY-N12817 |
Anti-inflammatory agent 80 |
Inhibitor |
/ |
Unkown |
| HY-N7614 |
Anemarrhenasaponin A2 |
|
95.38% |
Unkown |
| HY-N7857 |
19(R)-Hydroxy-prostaglandin F2α |
|
/ |
Unkown |
| HY-R00011 |
hsa-let-7f-2-3p mimic |
|
/ |
Unkown |
| HY-R00011A |
hsa-let-7f-2-3p agomir |
|
/ |
Unkown |
| HY-R02559 |
mmu-let-7f-2-3p mimic |
|
/ |
Unkown |
| HY-R02559A |
mmu-let-7f-2-3p agomir |
|
/ |
Unkown |
| HY-RI00011 |
hsa-let-7f-2-3p inhibitor |
|
/ |
Unkown |
| HY-RI00011A |
hsa-let-7f-2-3p antagomir |
|
/ |
Unkown |
| HY-RI02559 |
mmu-let-7f-2-3p inhibitor |
|
/ |
Unkown |
| HY-RI02559A |
mmu-let-7f-2-3p antagomir |
|
/ |
Unkown |
| HY-RS03480 |
CYP4F2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS04111 |
E2F2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS04630 |
F2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS04632 |
F2r Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS04633 |
F2r Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS04635 |
F2rl1 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS04636 |
F2rl1 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS04638 |
F2rl2 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS04639 |
F2rl2 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS04640 |
F2RL3 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS04641 |
F2rl3 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS04642 |
F2rl3 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS05897 |
GTF2F2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS10898 |
POU2F2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS10901 |
POU3F2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS10905 |
POU4F2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS10911 |
POU5F2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS10913 |
POU6F2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS13206 |
SLC35F2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS15223 |
TTF2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-W006069 |
H-Phe(3,5-DiF)-OH |
|
95.96% |
Unkown |
| HY-W112148 |
Dipyrazino[2,3-f:2',3'-h]quinoxalinehexacarboxylic acid |
|
/ |
Unkown |
| HY-W399193 |
PGF2α 1,9-lactone |
Inhibitor |
/ |
Unkown |
| HY-W456333 |
4,4',4'',4''',4'''',4'''''-(Dipyrazino[2,3-f:2',3'-h]quinoxaline-2,3,6,7,10,11-hexayl)hexabenzoic acid |
|
/ |
Unkown |
| HY-W543340 |
UIO-66-F2 |
|
/ |
Unkown |
| HY-W746807 |
Bimatoprost cyclohexyl amide |
Agonist |
/ |
Unkown |
| HY-W746888 |
17-Phenyl trinor prostaglandin F2α diethyl amide |
|
/ |
Unkown |
| HY-Y0110S |
2-Naphthol-d8 |
|
/ |
Unkown |
| HY-100571A |
(+)-5-trans Cloprostenol isopropyl ester |
|
/ |
Unkown |
| HY-103447S2 |
Zearalenone-13C7 |
Activator |
/ |
Unkown |
| HY-112284A |
Ebopiprant hydrochloride |
Antagonist |
/ |
Unkown |
| HY-113209S1 |
8-Isoprostaglandin F2α-d9 |
|
/ |
Unkown |
| HY-114695 |
Prostaglandin F2α-1-glyceryl ester |
|
/ |
Unkown |
| HY-114841 |
ONO 207 |
|
/ |
Unkown |
| HY-116502 |
13,14-Dihydro-15-keto prostaglandin F2α isopropyl ester |
|
/ |
Unkown |
| HY-116679 |
17-trifluoromethylphenyl trinor Prostaglandin F2α |
|
/ |
Unkown |
| HY-116889 |
15-Keto latanoprost acid |
|
/ |
Unkown |
| HY-118520 |
16-Phenoxy tetranor prostaglandin F2α methyl ester |
|
/ |
Unkown |
| HY-120982 |
(+)-15-epi Cloprostenol |
|
/ |
Unkown |
| HY-124175 |
16-Phenoxy prostaglandin F2α ethyl amide |
|
/ |
Unkown |
| HY-124243 |
N-Cyclopropyl methyl bimatoprost |
Agonist |
/ |
Unkown |
| HY-125946R |
Latanoprost lactone diol (Standard) |
|
/ |
Unkown |
| HY-137520 |
16-Phenoxy tetranor Prostaglandin F2α cyclopropyl methyl amide |
|
/ |
Unkown |
| HY-137547 |
20-Hydroxy-PGF2α |
|
/ |
Unkown |
| HY-149588 |
17-Trifluoromethylphenyl trinor prostaglandin F2α methyl ester |
|
/ |
Unkown |
| HY-149749 |
Methylthiomcresol-C3-COOH |
|
/ |
Unkown |
| HY-158782 |
5-trans Bimatoprost acid |
|
/ |
Unkown |
| HY-172634 |
8-Iso-17-phenyl trinor prostaglandin F2β |
|
/ |
Unkown |
| HY-174478 |
Mouse Pou3f2 mRNA |
|
/ |
Unkown |
| HY-174545 |
Human POU3F2 mRNA |
|
/ |
Unkown |
| HY-175062 |
8-iso Prostaglandin F2α ethanolamide |
|
/ |
Unkown |
| HY-176014 |
17-Phenyl trinor prostaglandin F2α glycinamide |
|
/ |
Unkown |
| HY-176017 |
2,3-Dinor fluprostenol |
|
/ |
Unkown |
| HY-176075 |
16-(3-Fluorophenoxy) tetranor prostaglandin F2α methyl |
|
/ |
Unkown |
| HY-176096 |
1α-Monohomo-17-phenyl trinor Prostaglandin F2α |
|
/ |
Unkown |
| HY-176833 |
Prostaglandin F2α diethyl amide |
|
/ |
Unkown |
| HY-178560 |
3'-β-F-2'-5-Me-dU |
|
/ |
Unkown |
| HY-179901 |
17-Phenyl trinor prostaglandin F2α isopropyl amide |
|
/ |
Unkown |
| HY-181444 |
16-Phenoxy tetranor Prostaglandin F2α methyl amide |
Ligand |
/ |
Unkown |
| HY-183944 |
BN80933 |
Inhibitor |
/ |
Unkown |
| HY-N15028 |
Depsidomycin |
Inhibitor |
/ |
Unkown |
| HY-N8085 |
Icariside F2 |
Inhibitor |
/ |
Unkown |
| HY-RS16873 |
F2 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS19321 |
E2f2 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS20069 |
Nr2f2 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS20583 |
Pou2f2 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS21172 |
Pou3f2 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS22308 |
Rpl3 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS23314 |
F2 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS25812 |
E2f2 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS26573 |
Nr2f2 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS27091 |
Pou2f2 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS27689 |
Pou3f2 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-W353470 |
2,3-Dinor-8-iso prostaglandin F 2α |
|
/ |
Unkown |
| HY-W408869 |
8-iso-13,14-dihydro-15-keto Prostaglandin F2α |
|
/ |
Unkown |
| HY-W472509 |
11-HETE |
Activator |
/ |
Unkown |
| HY-W592835 |
5'-O-DMT-4'-F-2-F-A-CE phosphoramidite |
|
/ |
Unkown |
| HY-W701877 |
Latanoprost tris(triethylsilyl) ether |
Control |
/ |
Unkown |
| HY-W746889 |
17-Phenyl trinor prostaglandin F2α 1,15-lactone |
|
/ |
Unkown |